Brought to you by 
Scios in Alzheimer's alliance with DuPont Merck
13 Jul 1999
Executive Summary
DuPont Merck and Scios will collaborate to find drugs that prevent Alzheimer's disease or retard its progression. As a first step, Scios will develop high-throughput screens to identify lead compounds from DuPont Merck's libraries.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Scios in Alzheimer's alliance with DuPont Merck
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice